Coherus is pleased to announce CMS has granted LOQTORZI® (toripalimab-tpzi) a product-specific J Code.
View Resource



From challenging misconceptions about breast cancer to incorporating paramedical tattooing for survivors after reconstruction, gather valuable takeaways from Oncology Issues in observance of Breast Cancer Awareness Month.
